https://www.selleckchem.com/pr....oducts/ulixertinib-b
Introduction. Nikkomycin Z (nikZ) is a chitin synthase inhibitor. Efficacy against Coccidioides has been demonstrated in animal models of pulmonary or brain infection. Its short half-life, in mice and humans, would necessitate divided daily dosing. We assayed nikZ efficacy in disseminated coccidioidomycosis (in a reduction of CFU design), and whether sustained release might be useful. Methods. Mice were challenged intravenously, with low or high arthroconidial inocula. Fluconazole, clinically the most commonly used
Like
Comment
Share
